Additional Investment in ...
MPI-2 Investment Limited Partnership (MPI), managed and operated by MedVenture Partners, Inc., participated in…READ MORE
Press Release
Office Relocation Notice...
We would like to inform you that MedVenture Partners, Inc. has relocated its office to “Nihonbashi Muromachi M…READ MORE
Establishment of MPI-2 In...
On November, 2019, MedVenture Partners Inc. together with Development Bank of Japan Inc., Fukoku Mutual Life I…READ MORE
Investment in A-Traction,...
“MPI-1 Investment Limited Partnership” (“MPI”), the fund managed by MedVenture Partners, Inc., has completed i…READ MORE
Chief Medical Officer, Dr...
Chief Medical Officer, Dr. Ikeno, delivered a lecture during the Japan-US Harmonization by Doing (HBD) session…READ MORE
During CRT15 that was hel...
During CRT15 that was held from February 21st through the 24th in Washington DC, MPI Chief Medical Officer Dr….READ MORE
President Hajime Oshita a...
MPI President Hajime Oshita and Chief Medical Officer Dr. Fumiaki Ikeno coordinated and delivered lectures at …READ MORE
Investment in Biomedical ...
“MPI-1 Investment Limited Partnership” (“MPI”), the fund managed by MedVenture Partners, Inc., has completed i…READ MORE
Addition of Three Compani...
MedVenture Partners, Inc. has approved and signed the contract agreement of the addition of Ushio, Inc., Tanak…READ MORE
Completion of First Inves...
“MPI-1 Investment Limited Partnership”, the first fund that is managed by MedVenture Partners Inc. has complet…READ MORE